Skip to main content
Log in

Live varicella zoster virus vaccine cost effective in elderly

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. van Hoek AJ, Gay N, Melegaro A, Opstelten W, Edmunds WJ.Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales. Vaccine 27: 1454-1467, No. 9, 25 Feb 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Live varicella zoster virus vaccine cost effective in elderly. Pharmacoecon. Outcomes News 573, 6 (2009). https://doi.org/10.2165/00151234-200905730-00017

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905730-00017

Keywords

Navigation